False narratives could undermine public confidence in an important tool that may help prevent or treat cancer in the future.

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of treatment that doctors hope will work against many types of tumors.

The experimental mRNA vaccine successfully cleared phase 3 clinical trials, the last step necessary before it can be approved ...

Cancer drugs are often designed to block specific molecular targets, but what happens after they enter a cell is not always ...

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the ...

Cancer spreading beyond the primary tumor—a process known as metastasis—is responsible for at least two-thirds of cancer ...

Operator: Good day, and welcome to the Bionano Second Quarter 26 Earnings Conference Call. Today's conference is being ...

Cancer diagnoses directly affect treatment decisions and prognosis and can even have life-altering consequences.

Narumi Harada-Shoji and colleagues report extended follow-up of the J-START trial and show that adjunctive ultrasonography plus mammography reduced the cumulative incidence of stage 2 and later breast ...

MarketsandMarkets™ projects the global biochips market to reach USD 21.36 billion by 2030 from USD 14.01 billion in 2025, ...

Stage 4 bone cancer, also known as metastatic bone cancer, is when cancer has spread from the bone to other parts of the body. Symptoms of stage 4 bone cancer may include persistent pain that worsens ...